Zobrazeno 1 - 10
of 1 287
pro vyhledávání: '"E. L. Nasonov"'
Autor:
B. S. Belov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 10-15 (2023)
In rheumatology, the problem of infectious pathology is quite acute. This is primarily due to the participation of various infectious agents in the development of immuno-inflammatory rheumatic diseases (IIRD), in which microorganisms play a trigger r
Externí odkaz:
https://doaj.org/article/0f64514153a5435b8d6f24e2aae1bba9
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 100-105 (2023)
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis.
Externí odkaz:
https://doaj.org/article/0c02e8fcf482449b86a55c10bf1303e0
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 16-24 (2023)
At the present stage of development of rheumatology, much attention is paid to the problem of comorbid infections, which have a significant impact on mortality and mortality, especially in immuno-inflammatory rheumatic diseases (IIRD). The active int
Externí odkaz:
https://doaj.org/article/2ec7095a64a7436ca46715a44f6c7e49
Autor:
V. I. Mazurov, A. M. Lila, M. A. Korolev, A. M. Prystrom, A. V. Kundzer, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, T. V. Plaksina, O. V. Antipova, D. G. Krechikova, S. A. Smakotina, O. A. Tciupa, E. V. Puntus, T. A. Raskina, L. N. Shilova, T. V. Kropotina, O. B. Nesmeyanova, T. A. Popova, I. B. Vinogradova, E. A. Dokukina, A. V. Plotnikova, P. S. Pukhtinskaia, A. V. Zinkina-Orikhan, Yu. N. Linkova, A. V. Eremeeva, A. A. Lutckii, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 87-99 (2023)
Background. Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active rheumatoid arthritis (RA) proved a superiority of levilimab over placebo. Here we present 1-y
Externí odkaz:
https://doaj.org/article/4769ca6bff3645e4857fcaa192e698f0
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 5-9 (2023)
Externí odkaz:
https://doaj.org/article/9aef6ec792bc43cab60d3cc91044b7a5
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 47-61 (2023)
Pericarditis, a clinical syndrome characterized by inflammation and thickening of the pericardium, is one of the most common forms of inflammatory diseases of the cardiovascular system. The most common and severe complication of acute pericarditis is
Externí odkaz:
https://doaj.org/article/d3f551f02a774f5f8bc4053f51219eeb
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 6, Pp 517-534 (2022)
Rheumatoid arthritis (RA) is an immune-mediated rheumatic disease (IMRDs) characterized by chronic erosive arthritis and systemic damage to internal organs, leading to early disability and reduced life expectancy in patients. A particularly important
Externí odkaz:
https://doaj.org/article/6aa1a7c164a64ee2bba6cff45fa2e18c
Autor:
E. L. Nasonov, M. S. Eliseev
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 6, Pp 638-641 (2022)
Externí odkaz:
https://doaj.org/article/858dee4c168b423e97c46d529c46aa94
Publikováno v:
Сеченовский вестник, Vol 0, Iss 4, Pp 53-57 (2022)
The present study considers a care of a 42-year old female patient with a severe variant of rheumatoid arthritis and extra-articular manifestations. The debut clinical symptoms included polyarthritis, fever, and anemia. On selection of a basic therap
Externí odkaz:
https://doaj.org/article/68fb35de04ea404a9e555eaad6e6bffb
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 5, Pp 560-565 (2022)
Aim – to determine the frequency of myocardial dysfunction using echocardiography with speckle tracking (STE) method, the relationship between a low global longitudinal strain (GLS) with the level of NT-proBNP, clinical and laboratory manifestation
Externí odkaz:
https://doaj.org/article/06ec802fd35a467e8d12a5e74a7d2a0f